Effect of processing delay and storage conditions on urine albumin-to-creatinine ratio

Effect of processing delay and storage conditions on urine albumin-to-creatinine ratio

<h4>Background and objectives</h4> <p>Because there is substantial biologic intraindividual variation in albumin excretion, randomized trials of albuminuria-reducing therapies may need multiple urine samples to estimate daily urinary albumin excretion. Mailing spot urine samples c...

Full description

Bibliographic Details
Main Authors:	Herrington, W, Illingworth, N, Staplin, N, Kumar, A, Storey, B, Hrusecka, R, Judge, P, Parish, S, Landray, M, Haynes, R, Baigent, C, Hill, M, Clark, S
Format:	Journal article
Published:	American Society for Nephrology 2016

Similar Items

KORELASI ANTARA KADAR PLASMA ENDOTELIN-1 DENGAN ALBUMIN CREATININ RATIO URIN PADA WANITA DIABETES MELITUS TIPE 2
by: , dr. Rusdiana, et al.
Published: (2013)

Use of gel-based separator tubes to stabilise phosphate in mailed blood samples.
by: Herrington, W, et al.
Published: (2015)

Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes
by: Rossing, P, et al.
Published: (2023)

Comparasion of Sport Urine Protein Creatinine From Three Different Time Urine Samples in Children With Primary Nephrotic
by: Perpustakaan UGM, i-lib
Published: (2007)

Perbandingan kadar albumin, proteintotal, urea, asam urat darah dan rasio urea/kreatinin urin sebelum dan sewaktu puasa ramadhan = Comparation of Blood Albumin, Total Protein, Uric Acid and Urinary Urea/Creatinin ...
by: Perpustakaan UGM, i-lib
Published: (2001)

Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (the 3C Study) – results of a randomized controlled clinical trial
by: Haynes, R, et al.
Published: (2018)

Renal and cardiovascular risk according to tertiles of urinary albumin-to-creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
by: Marcovecchio, M, et al.
Published: (2018)

Evidence for the prevention and treatment of stroke in dialysis patients
by: Herrington, W, et al.
Published: (2014)

Use of causal diagrams to inform the analysis and interpretation of observational studies: An example from the Study of Heart and Renal Protection (SHARP)
by: Staplin, N, et al.
Published: (2016)

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
by: Mafham, M, et al.
Published: (2017)

Limitations of the microalbumin/creatinine ratio in detecting early microalbuminuria in type 1 diabetes
by: Karunakaran, S, et al.
Published: (1999)

Conventional and genetic evidence on the association between adiposity and chronic kidney disease
by: Zhu, P, et al.
Published: (2020)

Impact of diabetes on the effects of sodium glucose co-transporter-2 (SGLT2) inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
by: Herrington, W, et al.
Published: (2022)

Urinary lactate :: Creatinine ratio as diagnostic test for hypoxic-ischemic encephalopathy in neonates with asphyxia
by: , HANUM P., Syarifah, et al.
Published: (2003)

Biliary tract and liver complications in polycystic kidney disease
by: Judge, P, et al.
Published: (2017)

The authors reply
by: Chapman, D, et al.
Published: (2023)

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy
by: Storey, B, et al.
Published: (2018)

Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease
by: Zhu, D, et al.
Published: (2025)

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank
by: Zhu, P, et al.
Published: (2020)

Kidney disease trials for the 21st century: innovations in design and conduct
by: Herrington, W, et al.
Published: (2019)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
by: Storey, B, et al.
Published: (2017)

Neprilysin inhibition in chronic kidney disease.
by: Judge, P, et al.
Published: (2014)

Conventional and genetic evidence on the association between adiposity and CKD
by: Zhu, P, et al.
Published: (2020)

Molecularly Imprinted Silica Matrix In Detection Of Creatinine
by: Florence, Chan
Published: (2017)

A NEUTRON REFLECTIVITY STUDY OF A SPREAD MONOLAYER OF BOVINE SERUM-ALBUMIN
by: Eaglesham, A, et al.
Published: (1992)

Korelasi kadar interferon-gamma serum dengan rasio albumin atau kreatinin urin pada penderita hipertensi esensial
by: , SARI, Lisa Kurnia, et al.
Published: (2010)

Interleukin-6-to-albumin ratio for mortality prediction in critically ill elderly patients
by: Yang, Lim Kai
Published: (2024)

Relationship between dietary protein intake and serum urea, uric acid and creatinine, and 24-hour urinary creatinine excretion: the BIRNH study /
by: 199370 Kesteloot, Hugo E., et al.

Reliability of major bleeding events in UK routine data vs clinical trial adjudicated follow-up data
by: Harper, C, et al.
Published: (2023)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
by: Harper, C, et al.
Published: (2021)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
by: Harper, C, et al.
Published: (2021)

Fibroblast growth factor-23 and risk of cardiovascular diseases: a Mendelian randomization study
by: Donovan, K, et al.
Published: (2022)

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial
by: Mayne, KM, et al.
Published: (2024)

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial
by: Mayne, K, et al.
Published: (2024)

Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: a randomised double-blind trial
by: Haynes, R, et al.
Published: (2018)

Accelerometer-measured physical activity and functional behaviours among people on dialysis
by: Nawab, KA, et al.
Published: (2020)

Existing creatinine-based equations overestimate glomerular filtration rate in Indians
by: Kumar, V, et al.
Published: (2018)

Risk factors for delayed graft function defined as need for dialysis or failure of creatinine to fall by 10% in the first 24 hours after transplant.
by: Stratopoulos, C, et al.
Published: (2008)

Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD
by: Lamprea-Montealegre, J, et al.
Published: (2019)

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
by: Herrington, W, et al.
Published: (2018)